摘要 |
<p>The invention relates to a process for preparing 1-phenyl-3-(4-chlorophenyl)-pyrazol-4-ylacetic acid, known under the generic name Lonazolac, and its calcium salt (Ca-Lonazolac). The process comprises the reductive hydrolysis of 1-phenyl-3-(4-chlorophenyl)-4-pyrazolecarboxaldehyde cyanohydrine using stannous chloride in a mixture of acetic acid, hydrochloric acid and preferably a catalytic amount of hydroiodic acid at elevated temperatures, and, if required, subsequent conversion of the acid into the calcium salt. The products are potent anti-inflammatory agents.</p> |
申请人 |
SPOFA SPOJENE PODNIKY PRO ZDRAVOTNICKOU VYROBU |
发明人 |
HAJICEK, JOSEF;PIHERA, PAVEL;BRUNOVA, BOHUMILA;MICHALSKY, JIRI, RNDR.;HRBATA, JIRI, DR.;FERENC, MILAN, RNDR. |